Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.78B |
| 2 |
Microsoft
MSFT
|
+$2.22B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.67B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.65B |
| 5 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$1.19B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.45B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$533M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$410M |
| 4 |
Stellantis
STLA
|
+$312M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.28% |
| 2 | Healthcare | 11.27% |
| 3 | Financials | 10.52% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1451
Transocean
RIG
$5.94B
| $3.97M | ﹤0.01% |
566,626
+355,689
| +169% | +$2.2M |
|
1452
Roivant Sciences
ROIV
$26B
| $3.93M | ﹤0.01% |
390,231
+158,363
| +68% | +$1.42M |
|
|
AAT
1453
American Assets Trust
AAT
$1.39B
| $3.93M | ﹤0.01% |
204,804
-11,229
| -5% | -$210K |
|
1454
Planet Fitness
PLNT
$3.99B
| $3.92M | ﹤0.01% |
58,103
+39,830
| +218% | +$2.86M |
|
1455
Rogers Corp
ROG
$2.4B
| $3.92M | ﹤0.01% |
24,183
-80,346
| -77% | -$12.7M |
|
1456
CNO Financial Group
CNO
$5.09B
| $3.91M | ﹤0.01% |
165,214
+31,741
| +24% | +$707K |
|
1457
Urban One Class D
UONEK
$24.8M
| $3.9M | ﹤0.01% |
65,021
+14,661
| +29% | +$833K |
|
|
CLVT.PRA
1458
DELISTED
Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares
CLVT.PRA
| $3.9M | ﹤0.01% |
94,905
+39,096
| +70% | +$1.47M |
|
1459
OneMain Financial
OMF
$7.43B
| $3.89M | ﹤0.01% |
89,083
+46,597
| +110% | +$1.82M |
|
1460
COPT Defense Properties
CDP
$4.23B
| $3.89M | ﹤0.01% |
163,871
+7,282
| +5% | +$170K |
|
1461
Starwood Property Trust
STWD
$6B
| $3.88M | ﹤0.01% |
200,220
+74,896
| +60% | +$1.33M |
|
1462
Relay Therapeutics
RLAY
$4.18B
| $3.88M | ﹤0.01% |
309,179
+114,709
| +59% | +$1.43M |
|
1463
Genpact
G
$5.81B
| $3.88M | ﹤0.01% |
103,314
+45,719
| +79% | +$1.84M |
|
1464
Travere Therapeutics
TVTX
$5.81B
| $3.88M | ﹤0.01% |
252,583
+49,797
| +25% | +$906K |
|
1465
AerCap
AER
$23.9B
| $3.88M | ﹤0.01% |
61,038
-37,128
| -38% | -$2.14M |
|
1466
Frontdoor
FTDR
$6.53B
| $3.87M | ﹤0.01% |
121,404
+11,874
| +11% | +$354K |
|
1467
BioCryst Pharmaceuticals
BCRX
$2.41B
| $3.87M | ﹤0.01% |
549,739
-153,434
| -22% | -$1.23M |
|
1468
Erie Indemnity
ERIE
$13.4B
| $3.87M | ﹤0.01% |
18,427
+711
| +4% | +$159K |
|
1469
Procore
PCOR
$8.63B
| $3.86M | ﹤0.01% |
59,296
+16,358
| +38% | +$962K |
|
1470
Sonoco
SON
$5.67B
| $3.85M | ﹤0.01% |
65,289
+43,524
| +200% | +$2.62M |
|
1471
Four Corners Property Trust
FCPT
$2.75B
| $3.85M | ﹤0.01% |
151,619
-147,279
| -49% | -$3.81M |
|
1472
CALL
SiriusXM
SIRI
$10.1B
| $3.85M | ﹤0.01% |
+85,000
| New | +$3.21M |
|
1473
BWX Technologies
BWXT
$15.6B
| $3.85M | ﹤0.01% |
53,758
+49,537
| +1,174% | +$3.24M |
|
|
MORF
1474
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $3.84M | ﹤0.01% |
66,994
+35,718
| +114% | +$1.87M |
|
1475
STAAR Surgical
STAA
$1.17B
| $3.84M | ﹤0.01% |
73,002
-67,499
| -48% | -$4.11M |
|
Similar funds
Barclays's Q2 2023 Portfolio in Review
As of Q2 2023, Barclays held 5,371 positions worth $158B, down 28% from $218B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays withdrew a net $70.1B in Q2 2023, closing 872 positions and reducing 1,669 holdings. Its most notable exit was DCP Midstream, LP, an estimated $47.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in State Street SPDR Nuveen ICE Municipal Bond ETF worth $36.9M.
- Barclays's largest Q2 2023 buy was State Street SPDR Nuveen ICE Municipal Bond ETF: 799,988 shares worth $36.9M.
- Barclays added most to Apple in Q2 2023, an estimated $2.78B increase.
- Barclays's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.45B.
- Barclays fully exited DCP Midstream, LP in Q2 2023, selling an estimated $47.3M.
- Barclays's ten largest holdings make up 24% of its $158B portfolio in Q2 2023.
- Barclays opened 314 new positions and closed 872 in Q2 2023.
- Barclays's portfolio value fell 28% quarter-over-quarter to $158B.
Based on Barclays's 13F filing for Q2 2023, filed 3 Aug 2023.